Doxorubicin

Category: Cancer



Doxorubicin Overview

Doxorubicin, sold under the trade names Adriamycin among others, is a chemotherapy medication used to treat cancer.[3] This includes breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia.[3] It is often used together with other chemotherapy agents.[3] Doxorubicin is given by injection into a vein.[3] Common side effects include hair loss, bone marrow suppression, vomiting, rash, and inflammatio...

Read more Doxorubicin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doxorubicin

Recent Doxorubicin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Doxorubicin
  • Injection: 100mg, 100mg/vial, 10mg, 10mg/vial, 20mg, 2mg/ml, 50mg, 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Doxorubicin: (61 results)

Showing the first 20, Sorted by National Drug Code
  • 0069-0170 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0171 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-3030 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3031 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3032 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3033 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3034 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4004 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4015 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4026 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4030 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4031 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4032 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4033 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4034 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4037 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0409-0124 Doxorubicin Hydrochloride 2 mg/ml Intra-arterial; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0703-5040 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-5043 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-5046 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 41 more results ...

Other drugs which contain Doxorubicin or a similar ingredient: (6 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA